Avatrombopag for the treatment of thrombocytopenia in children's patients following allogeneic hematopoietic stem-cell transplantation: A pilot study

Avatrombopag for the treatment of thrombocytopenia in children's patients following allogeneic hematopoietic stem-cell transplantation: A pilot study

Thrombocytopenia following allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a common and life-threatening complication. Thus, new prevention and treatment strategies for post-HSCT thrombocytopenia are urgently required. In recent studies, thrombopoietin receptor agonists (TPO-RA) fo...

Full description

Bibliographic Details
Main Authors: Yongsheng Ruan, Wei Cao, Tingting Luo, Xuan Liu, Qiujun Liu, Yuhua Xiao, Cuiling Wu, Danfeng Xie, Yuqiong Ren, Xuedong Wu, Xiaoqin Feng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Pediatrics
Subjects:
avatrombopag
thrombocytopenia
allogeneic hematopoietic stem cell transplantation
thrombopoietin receptor agonist
poor graft function
secondary failure of platelet recovery
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1099372/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2023.1099372/full

Similar Items